Health
FDA gives expedited approval to new groundbreaking pancreatic cancer drug
FDA officials approve first-of-a-kind pill called daraxonrasib to fight one of the deadliest types of cancer The US Food and Drug Adminis…
Story Brief
FDA officials approve first-of-a-kind pill called daraxonrasib to fight one of the deadliest types of cancer The US Food and Drug Administration (FDA) approved a groundbreaking new drug for the most common form of pancreatic cancer, offering US patients a more effective treatment against one of the deadliest types of the disease.
Read full article on The GuardianAI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- Gut tissue may retain inflammatory 'memory' for more than a yearContinue reading
- States try new tactics to bring down high hospital pricesContinue reading
- Vulnerability to wildfire smoke is in our genes, thanks to an evolutionary quirkContinue reading
- Report measures blue spaces as major public health assets in ScotlandContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow